Seeking Alpha午间综述提及DICK'S下调指引、原油下跌、Strategy比特币浮盈、Teva土耳其反垄断调查

Wall Street’s major market averages pushed higher on Tuesday as traders gear up for Nvidia results and inflation data set to land on Wednesday.
The blue-chip Dow (DJI) was last +0.1%, the benchmark S&P 500 (SP500) was last +0.2%, and the tech-focused Nasdaq Composite (COMP:IND) was last +0.5%.
Now, here are four news stories that broke in the morning to watch out for:
DICK'S cuts outlook: DICK'S Sporting Goods (DKS) shares tumbled double-digits at Tuesday's open after the retailer cut its profit outlook to reflect an increasingly promotional athletic footwear and apparel marketplace. Despite a surge in Q2 sales, results fell short of Wall Street's lofty expectations, with Executive Chairman Ed Stack noting that "conditions across portions of the athletic footwear and apparel marketplace became increasingly promotional." The impact reverberated across the sector, weighing on Nike, adidas, PUMA SE, On Holding, Deckers Outdoor, and Wolverine World Wide, while Academy Sports and Outdoors dipped to its lowest level in nine months.
Crude oil futures fall: October Nymex crude fell 2.7% to $82.67/bbl and October Brent dropped 2.8% to $89.61/bbl as the Trump administration pivoted to economic sanctions rather than military strikes to pressure Iran. The shift to economic pressure reduced some of the oil market's anxiety, with Saxo Bank's Ole Hansen noting Monday's sanctions announcement was not as forceful as traders had expected. Oil prices moved lower even after an oil tanker was struck Tuesday near the Strait of Hormuz by an unidentified projectile, with markets remaining in "wait-and-see mode" amid continuing flows through the strait.
Strategy records unrealized gains: Strategy (MSTR) saw a massive turnaround in its Bitcoin position as the cryptocurrency gained 22.57% over the past week to trade around $79.04K, transforming a roughly $9.5B unrealized loss into a $4.7B paper profit. According to the company's latest 8-K filing, Strategy held 840.45K BTC as of August 23 with an average cost basis of $75.39K per token. The company also strengthened its liquidity position, raising $2.01B from stock sales and holding $6.69B in USD assets.
Teva investigated in Turkey: Turkey's Competition Authority launched an investigation into Teva Pharmaceutical over allegations of restricting competition through "divisional" patent practices and misleading characterization of the efficacy and safety of rival products. The probe, initiated in early August, targets Teva subsidiaries Teva İlaçları San. ve Tic. AŞ and Teva Pharmaceuticals Europe B.V., as well as the parent company. The regulator did not specify which treatments are targeted in the investigation.